A new look at viruses in type 1 diabetes
1995; Wiley; Volume: 11; Issue: 2 Linguagem: Africâner
10.1002/dmr.5610110202
ISSN1099-0895
Autores Tópico(s)Immune Cell Function and Interaction
ResumoDiabetes/Metabolism ReviewsVolume 11, Issue 2 p. 83-107 Article A new look at viruses in type 1 diabetes Ji-Won Yoon, Corresponding Author Ji-Won Yoon Julya McFarlane Diabetes Research Centre and Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1Search for more papers by this author Ji-Won Yoon, Corresponding Author Ji-Won Yoon Julya McFarlane Diabetes Research Centre and Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1Search for more papers by this author First published: July 1995 https://doi.org/10.1002/dmr.5610110202Citations: 45AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rossini AA, Greiner DL, Friedman HP, and Mordes JP: Immunopathogenesis of diabetes mellitus. Diabetes Rev 1: 43–75, 1993. 2 Yoon JW: Viral pathogenesis of insulin-dependent diabetes mellitus. In Autoimmunity and the Pathogenesis of Diabetes, F Ginsberg-Fellner, and RC McEvoy, Eds. Springer-Verlag, New York, 1990, pp 206–255. 3 Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, and Cudworth AG: Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet 2: 1363–1365, 1981. 4 Drell DW, and Notkins AL: Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 132–143, 1987. 5 Pyke DA: The genetic perspective—putting research into practice. In Diabetes 1988. RG Larkins, PZ Zimmet, and DJ Chisholm, Eds. Exerpta Medica, Amsterdam, 1989, pp 1227–1230. 6 Horn G, Bugawan T, Long C, and Erlich H: Allelic sequence of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 85: 6012–6016, 1988. 7 Todd JA, and Bain SC: A practical approach to identification of susceptibility genes for IDDM. Diabetes 41: 1029–1034, 1992. 8 Segall M: HLA and the genetics of IDDM: holism versus reductionism. Diabetes 37: 1005–1008, 1988. 9 Sheehy M, Scharf S, Rowe J, Neme de Gimenez M, Meske L, Erlich H, and Nepom BS: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and DQ alleles. J Clin Invest 83: 830–835, 1989. 10 Barnett AH, Eff C, Leslie RDG, and Pyke DA: Diabetes in identical twins. A study of 200 pairs. Diabetologia 20: 87–93, 1981. 11 Yoon JW: Role of viruses and environmental factors in induction of diabetes. In Human Diabetes: Genetic, Environmental and Autoimmune Etiology, S Baekkeskov, and B Hansen, Eds. Springer-Verlag, New York, 1990, pp 95–123. 12 Adams SF: The seasonal variation in the onset of acute diabetes. Arch Intern Med 37: 861–862, 1926. 13 Gamble DR, and Taylor KW: Seasonal incidence of diabetes mellitus. Br Med J 3: 631–633, 1969. 14 Harris HF: A case of diabetes mellitus quickly following mumps on the pathological alterations of salivary glands, closely resembling those found in pancreas, in a case of diabetes mellitus. Boston Med Surg J CXL: 465, 1898. 15 Szopa TM, Titchener PA, Portwood ND, and Taylor KW: Diabetes mellitus due to viruses—some recent developments. Diabetologia 36: 687–695, 1993. 16 Champsaur H, Bottazzo G, Bertrams J, Assan R, and Bach C: Virologic, immunologic and genetic factors in insulin-dependent diabetes mellitus. J Pediatrics 100: 15–20, 1982. 17 Yoon JW, Austin M, Onodera T, and Notkins AL: Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179, 1979. 18 Craighead JE, and McLane MF: Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 162: 913–915, 1968. 19 Coleman TJ, Taylor KW, and Gamble DR: The development of diabetes following Coxsackie B virus infection in mice. Diabetologia 10: 755–759, 1974. 20 Yoon JW, Onodera T, and Notkins AL: Virus-induced diabetes mellitus: beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J Exp Med 148: 1068–1080, 1978. 21 Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, and Welsh RM: Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254: 1010–1013, 1991. 22 Rayfield E, Kelly K, and Yoon JW: Rubella virus-induced diabetes in hamsters. Diabetes 35: 1276–1281, 1986. 23 Suenaga K, and Yoon JW: Association of beta cell-specific expression of endogenous retrovirus with the development of insulitis and diabetes in NOD mice. Diabetes 37: 1722–1726, 1988. 24 Gaskins H, Prochazka M, Hamaguchi K, Serreze D, and Leiter E: Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. J Clin Invest 90: 2220–2227, 1992. 25 Tajima M, Yazawa T, Hagiwara K, Kurosawa T, and Takahashi K: Diabetes mellitus in cattle infected with bovine viral diarrhea mucosal disease virus. J Vet Med Assoc 39: 616–620, 1992. 26 Oldstone MBA: Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 239: 500–502, 1988. 27 Dyrberg T, Schwimmbeck PL, and Oldstone MBA: Inhibition of diabetes in BB rats by viral infection. J Clin Invest 81: 928–931, 1988. 28 Wilberz S, Partke HJ, Dagnaes-Hansen F, and Herberg L: Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34: 2–5, 1991. 29 Yoon JW: Viruses as triggering agents of insulin-dependent diabetes mellitus. In The Causes of Diabetes, RDG Leslie, Ed. John Wiley, New York, 1993, pp 83–103. 30 Schattner A, and Rager-Zisman B: Virus-induced autoimmunity. Rev Infect Dis 12: 204–222, 1990. 31 Talal N, Flescher E, and Dang H: Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 5 (Suppl A): 61–66, 1992. 32 Onodera T, Toniolo A, Ray UR, Jenson AB, Knazek RA, and Notkins AL: Virus-induced diabetes mellitus. J Exp Med 153: 1457–1465, 1981. 33 Hao W, Serreze DV, McCulloch DK, Neifing JL, and Palmer JP: Insulin (auto) antibodies from human IDDM cross-react with retroviral antigen p73. J Autoimmun 6: 787–798, 1993. 34 Gamble DR: Relation of antecedent illness to development of diabetes in children. Br Med J 2: 99–101, 1980. 35 Helmke K, Otten A, and Willems W: Islet cell antibodies in children with mumps infection. Lancet 2: 211–222, 1980. 36 Patterson K, Chandra R, and Jenson A: Congenital rubella, insulitis and diabetes mellitus in an infant. Lancet 1: 1048–1049, 1981. 37 Smithells R, Sheppard S, Marshall W, and Peckham C: Congenital rubella and diabetes mellitus. Lancet 1: 439, 1978. 38 Schopfer K, Matter L, Flueler U, and Werder E: Diabetes mellitus, endocrine autoantibodies and prenatal rubella infection. Lancet 2: 159, 1982. 39 Menser MA, Forrest J, and Bransby R: Rubella infection and diabetes mellitus. Lancet 1: 57–60, 1978. 40 Forrest J, Menser MA, and Burgess J: High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1: 332–334, 1971. 41 McEvoy R, Cooper L, Rubinstein P, Fedun B, and Ginsberg-Fellner F: Type I diabetes mellitus (IDDM) and autoimmunity in patients with congenital rubella syndrome (CRS): increased incidence of insulin autoantibodies. Diabetes 35: 187A, 1986. 42 Rabinowe S, George K, Loughlin R, and Soeldner J: Predisposition to type I diabetes and organ-specific autoimmunity in congenital rubella: T cell abnormalities in young adults. Diabetes 35: 187A, 1986. 43 Ginsberg-Fellner F, Witt ME, and Fedun B: Diabetes mellitus and autoimmunity in patients with congenital rubella syndrome. Rev Infect Dis 7 (Suppl 1): S170–175, 1985. 44 McIntosh EDG, and Menser MA: A fifty-year follow-up of congenital rubella. Lancet 340: 414–415, 1992. 45 Ward KP, Galloway WH, and Auchterlonie IA: Congenital cytomegalovirus infection and diabetes. Lancet 1: 497, 1979. 46 Yasumoto N, Hara M, Kitamoto YU, Nakayama M, and Sato T: Cytomegalovirus infection associated with acute pancreatitis, rhabdomyolysis and renal failure. Intern Med 31: 426–430, 1992. 47 Pak CY, Eun HM, McArthur RG, and Yoon JW: Association of cytomegalovirus infection with autoimmune type I diabetes. Lancet 2: 1–4, 1988. 48 Pak CY, Cha CY, Rajotte RV, McArthur RG, and Yoon JW: Human pancreatic islet cell-specific 38 kDa autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 33: 569–572, 1990. 49 Hyöty H, Rasanen L, Hiltunen M, Lehtinen M, Huupponen T, and Leinikki P: Decreased antibody reactivity to Epstein–Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. APMIS 99: 359–363, 1991. 50 Parkkonen P, Hyöty H, Ilonen J, Reijonen H, Yla-Herttuala S, and Leinikki P: Antibody reactivity to an Epstein–Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 β chain. Clin Exp Immunol 95: 287–293, 1994. 51 Yoon JW, and Kominek H: Role of Coxsackie B viruses in the pathogenesis of diabetes mellitus. In Microbial Infections and Pathogenesis. NR Rose, and H Friedman, Eds. Plenum Press, New York (in press). 52 Ihm SH, Lee KU, and Yoon JW: Virus-induced autoimmunity. In The Immunogenetics of Autoimmune Diseases, Vol. 1, N Farid, Ed. CRC Press, Boston, 1991, pp 125–134. 53 Lee KU, Amano K, and Yoon JW: Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 37: 1989–1991, 1988. 54 Charlton B, Bacelj A, and Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930–935, 1988. 55 Pak CY, Jun HS, Lee M, and Yoon JW: Beta cell-specific expression of retroviral mRNAs and group-specific antigen and the development of beta cell-specific autoimmunity in non-obese diabetic mice. Autoimmunity, (in press). 56 Fukino-Kurihara H, Fujita H, Hakura A, Nonaka K, and Tarui S: Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch 49: 107–120, 1985. 57 Nakagawa C, Hanafusa T, Miyagawa J, Yutsudo M, Nakajima H, Yakamoto K, Tomita K, and Kono N: Retrovirus gag protein p30 in the islets of nonobese diabetic mice: relevance for pathogenesis of diabetes mellitus. Diabetologia 35: 614–618, 1992. 58 Query CC, and Keene JD: A human autoimmune protein associated with U1 RNA contains a region of homology that is crossreactive with retroviral P30gag antigen. Cell 51: 211–220, 1987. 59 Nyman U, Lundberg I, Hedfors E, and Pettersson I: Recombinant 70-kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol 81: 52–58, 1990. 60 Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJW, Shattles WG, Clark DA, Entwistle A, and Maini RN: The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 31: 735–742, 1992. 61 Lagaye S, Vexiau P, Morozov V, Saal F, Gony J, Poorters AM, Loosfeld-Poirot Y, Hors J, Cathelineau G, Emanoil-Ravier R, and Peries J: Detection of HTLV-1 gag related sequences in leucocyte DNA from patients with polyendocrinopathies (Basendow–Graves' disease and insulin-dependent diabetes). CR Acad Sci Paris Ser. III 312: 309–315, 1991. 62 Onodera T, Jenson AB, Yoon JW, and Notkins AL: Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 301: 529–531, 1978. 63 Onodera T, Ray UR, Melez KA, Suzuki H, Toniolo A, and Notkins AL: Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 297: 66–69, 1982. 64 Yoon JW, Selvaggio S, Onodera T, Wheeler J, and Jenson AB: Infection of cultured human pancreatic β cell with reovirus type 3. Diabetologia 20: 462–467, 1981. 65 Marliss EB: The Juvenile Diabetes Foundation workshop on spontaneously diabetic BB rat as potential for insight into human juvenile diabetes. Metab Clin Exp 32 (Suppl 1): 1–166, 1983. 66 Brown DW, Welsh RM, and Like AA: Infection of peripancreatic lymph nodes but not islets precedes Kilham's rat virus-induced diabetes in BB/Wor rats. J Virol 67: 5873–5878, 1993. 67 Prince G, Jenson AB, Billups L, and Notkins AL: Infection of human pancreatic beta cell cultures with mumps virus. Nature 27: 158–161, 1978. 68 Hyöty H, Hiltunen M, Reunanen A, Leinikki P, Vesikari T, Lounamaa R, Tuomilehto J, and Akerblom HK: Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps–measles–rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 36: 1303–1308, 1993. 69 Cavallo MG, Baroni MG, Toto A, Gearing AJ, Forsey T, Andreani D, Thorpe R, and Pozzilli P: Viral infection induces cytokine release by beta islet cells. Immunology 75: 664–668, 1992. 70 Parkkonen P, Hyöty H, Koskinen L, and Leinikki P: Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia 35: 63–69, 1992. 71 Ginsberg-Fellner F, Witt ME, and Yagihaski S: Congenital rubella-syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 27: 87–89, 1984. 72 Ginsberg-Fellner F, Fedun B, Cooper LZ, Witt ME, Franklin BH, Roman SH, Rubenstein P, and McEvoy RC: Interrelationships of congenital rubella and type 1 insulin-dependent diabetes mellitus. In The Immuunology of Diabetes Mellitus, MA Jaworski, GD Molnar, RV Rajotte, and B Singh, Eds. Elsevier, Amsterdam, 1986, pp 279–286. 73 Karounos DG, Wolinsky JS, and Thomas JW: Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 150: 3080–3085, 1993. 74 Sibley JT: Concurrent onset of adult onset Still's disease and insulin dependent diabetes mellitus. Ann Rheum Dis 49: 547–548, 1990. 75 Numazaki K, Goldman H, Wong I, and Wainberg MA: Infection of cultured human fetal pancreatic islet cells by rubella virus. Am J Clin Pathol 91: 446–451, 1989. 76 Numazaki K, Goldman H, Seemayer TA, Wong I, and Wainberg MA: Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo 4: 49–54, 1990. 77 Kimura N, Fujiya H, Yamaguchi K, Takahashi T, and Nagura H: Vanished islets with pancreatitis in acute-onset insulin-dependent diabetes mellitus in an adult. Arch Pathol Lab Med 118: 84–88, 1994. 78 Jenson AB, Rosenberg HS, and Notkins AL: Pancreatic islet cell damage in children with fatal viral infections. Lancet 2: 354–458, 1980. 79 Onodera T, Suzuki H, Toniolo A, and Notkins AL: Virus-induced diabetes: cytomegalovirus and multiple environmental insults. Diabetologia 24: 218–224, 1983. 80 Ivarsson SA, Lindberg B, Nilsson KO, Ahlfors K, and Svanberg L: The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabetic Med 10: 521–523, 1993. 81 Nicoletti F, Scalia G, Lunetta M, Condorellia F, DiMauro M, Barcellini W, Stracuzzi S, Pagano M, and Meroni PL: Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patient. Clin Immunol Immunopathol 55: 139–147, 1990. 82 Fox GJ, and Murphy JC: Cytomegalic virus-associated insulitis in diabetic Octodon degus. Vet Pathol 16: 625–628, 1979. 83 Surcel HM, Ilonen J, Kaar ML, Hyöty H, and Leinikki P: Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr Scand 77: 471–474, 1988. 84 Sairenji T, Daibata M, Sorli CH, Qvistback H, Humphreys RE, Ludvigsson J, Palmer J, Landin-Olsson M, Sundkvist G, Michelsen B, Lernmark A, and Dyrberg T: Relating homology between the Epstein–Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 33–39, 1991. 85 Roman L, Simons L, Hammer R, Sambrook J, and Gething M: The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 61: 383–396, 1990. 86 Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B, Malissen B, Zinkernagel RM, and Hengartner H: Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305–317, 1991. 87 Oldstone MBA, Nerenberg M, Southern P, Price J, and Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319–331, 1991. 88 Laufer TM, von Herrath MG, Grusby MJ, Oldstone MB, and Glimcher LH: Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med 178: 589–596, 1993. 89 Aichele P, Kyburz D, Ohashi PS, Odermatt B, Zinkernagel RM, Hengartner H, and Pircher H: Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci USA 91: 444–448, 1994. 90 Holers VM, Hollis GF, Schwartz BD, Evans RJ, Strauss-Schoenberger J, Carel JC, Barney DL, Li B, Stafford-Hollis J, and Lacy PE: Induction of peri-insulitis but not diabetes in islet transplants expressing a single foreign antigen. A multi-stage model of disease. J Immunol 151: 5041–5052, 1993. 91 Ohashi PS, Oehen S, Aichele P, Pircher H, Odermatt B, Herrera P, Higuchi Y, Buerki K, Hengartner H, and Zinkernagel RM: Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α. J Immunol 150: 5185–5194, 1993. 92 Oehen S, Ohashi PS, Aichele P, Buerki K, Hengartner H, and Zinkernagel RM: Vaccination or tolerance to prevent diabetes. Eur J Immunol 22: 3149–3153, 1992. 93 Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, Pircher H, Gray GS, Ohashi PS, Freeman GJ, Nadler LM, June CH, and Aichele P: Mice expressing both B7–1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci USA 91: 3137–3141, 1994. 94 Ross ME, Onodera T, Brown KS, and Notkins AL: Virus-induced diabetes mellitus. IV. Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus. Diabetes 25: 190–197, 1976. 95 Yoon JW, Onodera T, and Notkins AL: Virus-induced diabetes mellitus. IX. Studies on virus passage and dose in susceptible and resistant strains of mice. J Gen Virol 27: 225–232, 1977. 96 Yoon JW: Virus induced diabetes mellitus. In Virus Infection and Diabetes Mellitus. Y Becker, Ed. Martinus Nijhoff, Boston, 1987, pp 209–231. 97 Kang Y, and Yoon JW: A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. J Gen Virol 74: 1203–1213, 1993. 98 Yoon JW, McClintock PR, Onodera T, and Notkins AL: Virus-induced diabetes mellitus. Inhibition by a non-diabetogenic variant of encephalomyocarditis virus. J Exp Med 152: 878–892, 1980. 99 Bae YS, Eun HM, and Yoon JW: Molecular identification of viral gene. Diabetes 38: 316–320, 1989. 100 Bae YS, Eun HM, and Yoon JW: Genomic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 170: 282–287, 1989. 101 Bae YS, and Yoon JW: Determination of diabetogenicity attributable to a single amino acid, Ala-776, on the polyprotein of encephalomyocarditis virus. Diabetes 42: 435–443, 1993. 102 Eun HM, Bae YS, and Yoon JW: Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 163: 369–373, 1988. 103 Kaptur PE, Thomas DC, and Giron DJ: Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Diabetes 38: 1103–1108, 1989. 104 Yoon JW, and Bae YS: Development of insulin-dependent diabetes in animals: control by a single gene of the host and a single amino acid of the virus. In Frontiers in Diabetes Research: Lessons from Animal Diabetes III. E Shafrir, Ed. Smith-Gordon and Co Ltd, London 1989, pp 51–60. 105 Onodera T, Yoon JW, Brown K, and Notkins AL: Virus-induuced diabetes mellitus: evidence for control by a single locus. Nature 274: 693–696, 1978. 106 Yoon JW, Lesniak MA, Fussganger R, and Notkins AL: Genetic differences in susceptibility of pancreatic β cells to virus-induced diabetes mellitus. Nature 264: 178–180, 1976. 107 Chairez R, Yoon JW, and Notkins AL: Virus-induced diabetes mellitus. X. Attachment of encephalomyocarditis virus and permissiveness of cultured β cells to infection. Virology 85: 606–611, 1978. 108 Yoon JW, and Notkins AL: Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic B-cells. J Exp Med 143: 1170–1185, 1976. 109 Buschard K, Hastrup N, and Rygaard J: Virus-induced diabetes mellitus in mice and the thymus-dependent immune system. Diabetologia 24: 42–46, 1983. 110 Yoon JW, McClintock PR, Bachurski CJ, Longstreth JD, and Notkins AL: Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta cells by encephalomyocarditis virus. Diabetes 34: 922–925, 1985. 111 Vialettes B, Baume D, Charpin C, DeMaeyer-Guignard J, and Vague P: Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon. J Clin Lab Immunol 10: 35–40, 1983. 112 Baek HS, and Yoon JW: Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 64: 5708–5715, 1990. 113 Baek HS, and Yoon JW: Direct involvement of macrophages in destruction of β cells leading to the development of diabetes in virus-infected mice. Diabetes 40: 269–274, 1991. 114 Yoon JW, Rodrigues MM, Currier C, and Notkins AL: Long term complications of virus-induced diabetes in mice. Nature 296: 567–569, 1982. 115 Yoon JW, and Reddi AH: Decreased bone formation and mineralization in virus induced diabetes mellitus. Am J Physiol 246: C177–C179, 1984. 116 Shichinohe K, Shimizu M, Ishizaki M, and Asakawa M: Kidney complications in EMC virus-induced diabetes in conventional DBA/2 male mice. Exp Anim 39: 113–116, 1990. 117 Morishima T, McClintock PR, Auklakh GS, Billups LC, and Notkins AL: Genomic and receptor attachment difference between mengovirus and encephalo-myocarditis virus. Virology 122: 461–465, 1982. 118 Yoon JW, Morishima T, McClintock PR, Austin M, and Notkins AL: Virus-induced diabetes mellitus: mengovirus infects pancreatic beta cells in strains of mice resistant to encephalomyocarditis virus. J Virol 50: 684–690, 1984. 119 Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, and Taylor KW: Viral antibodies in diabetes mellitus. Br Med J 3: 627–630, 1969. 120 Friman G, Fohlman J, Frisk G, Diderholm H, Ewald U, Kobbah M, and Tuvemo T: An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Acta Pediatr Scand 320 (Suppl): 14–19, 1985. 121 Banatvala J, Schernthaner G, Schober E, DeSilva L, Bryant J, Borkenstein M, Schober E, Brown D, DeSilva LM, Menser MA, and Silink M: Coxsackie B, mumps, rubella and cytomegalo-virus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1: 1409–1412, 1985. 122 King M, Shaikh A, Bidwell D, Voller A, and Banatvala J: Coxsackie B-virus specific IgM responses in children with insulin-dependent diabetes mellitus. Lancet 1: 1397–1399, 1983. 123 Mertens T, Gruneklee D, and Eggers HJ: Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes. Eur J Pediatr 140: 293–294, 1983. 124 Mirkovic RR, Varma KS, and Yoon JW: Incidence of Coxsackievirus B type 4 (CB4) infection concomitant with onset of insulin-dependent diabetes mellitus. J Med Virol 14: 9–16, 1984. 125 Buschard K, and Madsbad SA: Longitudinal study of virus antibodies in patients with newly diagnosed type 1 (insulin-dependent) diabetes mellitus. J Clin Lab Immunol 13: 65–70, 1984. 126 Frisk G, Fohlman J, Kobbah M, Ewald U, Tuvemo T, Diderholm H, and Friman G: High frequency of Coxsackie-B-virus-specific IgM in children developing during a period of high diabetes morbidity. J Med Virol 17: 219–227, 1985. 127 Alberti AM, Amato C, Candela A, Constantino F, Grandolfo ME, Lombardi F, Novello F, Orsini M, and Santoro R: Serum antibodies against Coxsackie B1–6 viruses in type 1 diabetics. Acta Diabetol Lat 22: 33–38, 1985. 128 Fohlman J, Bohme J, Rask L, Frisk G, Diderholm H, Friman G, and Tuvemo T: Matching of host genotype and serotypes of Coxsackie B virus in the development of juvenile diabetes. Scand J Immunol 26: 105–110, 1987. 129 Michlakova D, Petrovicova A, Kolar J, Jancova E, and Silesova J: The role of Coxsackie virus infection in the development of type 1 diabetes mellitus and its effect on the postinitial course of the disease in childhood. Cesk Pediatr 44: 257–262, 1989. 130 Michalkova D, Kostal M, Rajcani J, Petrovicova A, Bircak J, Kolar J, Barak L, and Hrabcakova D: Cytoplasmic islet cell antibodies in children with type I diabetes. Bratisl Lek Listy 90: 159–167, 1989. 131 Verma IC: The challenge of childhood diabetes mellitus in India. Indian J Pediatr 56 (Suppl 1): S33–S38, 1989. 132 Tuskiewicz-Misztal E: Epidemiologic factors and serum antibody titer to Coxsackie B-4 virus in patients with type I diabetes. Kinderaerztl Prax 59: 88–91, 1991. 133 Frisk G, Friman G, Tuvemo T, Fohlman J, and Diderholm H: Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 35: 249–253, 1992. 134 Gamble DR, Taylor KW, and Cumming H: Coxsackie viruses and diabetes mellitus. Br Med J 4: 260–262, 1973. 135 Wagenknecht L, Roseman J, and Herman W: Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackie virus B5. Am J Epidemiol 133: 1024–1031, 1991. 136 Palmer JP, Cooney MK, Crossley JR, Hollander PH, and Asplin CM: Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients. Diabetes Care 4: 525–528, 1981. 137 Pagano G, Cavallo-Perin P, Cavallo TF, Dall'Omo AM, Mascioloa P, Surinani R, Amoroso A, Curtoni SE, Borelli I, and Lenti G: Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12 month follow-up of an Italian population. Diabetes 36: 859–863, 1987. 138 Emekdas G, Rota S, Kusitmur S, and Kocabeyoglu O: Antibody levels against Coxsackie B viruses in patients with type 1 diabetes mellitus. Mikrobiyol Bul 26: 116–120, 1992. 139 Gunczler P, Lanes R, Layrisse Z, Esparza B, Salas R, Hernandez L, and Arnaiz-Villena A: Epidemiology and immunogenetics in recently diagnosed Venezuelan children with insulin-dependent diabetes mellitus. J Pediatr Endocrinol 6: 165–171, 1993. 140 Ajuw
Referência(s)